ZA92275B - Use of nadh and nadph as energy substitutes - Google Patents

Use of nadh and nadph as energy substitutes

Info

Publication number
ZA92275B
ZA92275B ZA92275A ZA92275A ZA92275B ZA 92275 B ZA92275 B ZA 92275B ZA 92275 A ZA92275 A ZA 92275A ZA 92275 A ZA92275 A ZA 92275A ZA 92275 B ZA92275 B ZA 92275B
Authority
ZA
South Africa
Prior art keywords
nadh
nadph
reduced form
adenine dinucleotide
nicotinamide adenine
Prior art date
Application number
ZA92275A
Other languages
English (en)
Inventor
Jorg Birkmayer
Birkmayer Jorg
Walter Birkmayer
Birkmayer Walter
Original Assignee
Birkmayer Joerg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Birkmayer Joerg filed Critical Birkmayer Joerg
Publication of ZA92275B publication Critical patent/ZA92275B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Dental Preparations (AREA)
  • Fodder In General (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA92275A 1991-01-24 1992-01-14 Use of nadh and nadph as energy substitutes ZA92275B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4102240A DE4102240C1 (ja) 1991-01-24 1991-01-24

Publications (1)

Publication Number Publication Date
ZA92275B true ZA92275B (en) 1992-12-30

Family

ID=6423720

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92275A ZA92275B (en) 1991-01-24 1992-01-14 Use of nadh and nadph as energy substitutes

Country Status (14)

Country Link
EP (1) EP0496479B1 (ja)
JP (1) JP2533709B2 (ja)
AT (1) ATE112664T1 (ja)
AU (1) AU663479B2 (ja)
BR (1) BR9200207A (ja)
CA (1) CA2059510C (ja)
DE (2) DE4102240C1 (ja)
DK (1) DK0496479T3 (ja)
ES (1) ES2061313T3 (ja)
FI (1) FI920323A (ja)
HU (1) HU9200213D0 (ja)
IE (1) IE69861B1 (ja)
NO (1) NO304672B1 (ja)
ZA (1) ZA92275B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668114A (en) 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2735293A1 (en) * 1995-01-17 1996-07-18 Menuco Corp. Nadh and nadph therapeutic agents for dermal administration
US5712259A (en) * 1996-04-22 1998-01-27 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating chronic fatigue syndrome
IT1318565B1 (it) * 2000-06-09 2003-08-27 World Pharma Tech Ltd Integratore alimentare proenergetico a base di nadh octocosanolo evitamina e.
US20040126751A1 (en) * 2002-12-27 2004-07-01 Birkmayer Jorg G.D. Method of prolonging the life-span of living cells using NADH, NADPH and ADP-ribose
DE102008010245B4 (de) * 2008-02-20 2011-02-10 Emag Holding Gmbh Verfahren zum Schleifen wellenförmiger Werkstücke
DE102014103443A1 (de) * 2014-03-13 2015-09-17 Jürgen Ruhlmann Komposition zur Verwendung zur Behandlung von Müdigkeit, Konzentrationsschwäche, Entzugserscheinungen, Kopfschmerzen und Erkältungskrankheiten, insbesondere Leistungsabfall, Kater und Müdigkeit
WO2020021734A1 (ja) * 2018-07-26 2020-01-30 オリジンバイオテクノロジー株式会社 機能性鶏卵及びその生産方法
DE202022000567U1 (de) 2022-03-06 2022-03-16 Penta Phi Eg Liposomale Formulierung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3594475A (en) * 1968-04-24 1971-07-20 Kyowa Hakko Kogyo Kk Method of treating and preventing the side effects of antibiotics
EP0107161B1 (de) * 1982-10-26 1989-08-09 CTA Finanz AG Mittel und Verfahren zur Optimierung der Gewebemasse von Organen innerhalb der genetischen Schwankungsbreite bei Menschen und Tieren
IT1162938B (it) * 1983-08-26 1987-04-01 Dino Spisni Composizione per la cura dei tumori maligni in particolare sugli animali
JPS60126220A (ja) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc 核酸成分組成物
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
JP2736103B2 (ja) * 1988-03-01 1998-04-02 ヴァルター・ビルクマイヤー パーキンソン症候群の治療用医薬、およびその製造方法
AT397201B (de) * 1988-06-03 1994-02-25 Birkmayer Joerg Ddr Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668114A (en) 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension

Also Published As

Publication number Publication date
DE59200603D1 (de) 1994-11-17
NO920315D0 (no) 1992-01-23
ATE112664T1 (de) 1994-10-15
FI920323A (fi) 1992-07-25
HU9200213D0 (en) 1992-04-28
NO920315L (no) 1992-07-27
BR9200207A (pt) 1992-10-06
DK0496479T3 (da) 1995-04-18
CA2059510C (en) 1997-06-10
JPH05262652A (ja) 1993-10-12
EP0496479A1 (de) 1992-07-29
DE4102240C1 (ja) 1992-04-09
AU663479B2 (en) 1995-10-12
CA2059510A1 (en) 1992-07-25
NO304672B1 (no) 1999-02-01
IE920198A1 (en) 1992-07-29
AU1039292A (en) 1992-07-30
JP2533709B2 (ja) 1996-09-11
ES2061313T3 (es) 1994-12-01
IE69861B1 (en) 1996-10-16
EP0496479B1 (de) 1994-10-12
FI920323A0 (fi) 1992-01-24

Similar Documents

Publication Publication Date Title
AU9062291A (en) Formulation for treating silage
AU1301292A (en) Novel benzo-fused lactams that promote the release of growth hormone
AU655462B2 (en) Use of hydrocolloids for formulating and processing of low fat water activity confectionery products and process
CA2054358A1 (en) High acid nutritional formulations
CA2102210A1 (en) Combined Calcium and Vitamin D Supplements
AU5609186A (en) Dietary products & uses comprising methylsulfonymethane
EP0455808A4 (en) Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
ES2054697T3 (es) Un producto higienico, particularmente para la conservacion de la dentadura de un perro.
ZA92275B (en) Use of nadh and nadph as energy substitutes
NZ240011A (en) Oil-in-water emulsion nutritional composition: processes for production
Albrektsen et al. Ascorbyl palmitate as a dietary vitamin C source for rainbow trout (Salmo gairdneri)
EP0174821A3 (en) Methods of treating vegetable foods for animals and fragrance compositions for use therein
AU5744286A (en) Potassium, sodium or calcium formate additive for inhibiting respiration of and promoting desiccation of crops
ES553196A0 (es) Procedimiento para la obtencion del acido propionico, sal amonica (2:1), y productos derivados utilizables en la conservacion de alimentos para consumo humano y animal
GR3007290T3 (ja)
CA2124925A1 (en) Preparation of dietary fatty acid salt products
GB2016900A (en) Concentrated food product
Riopel et al. Coronary risk factor modification in children: smoking. A statement for physicians by the Committee on Atherosclerosis and Hypertension in Childhood of the Council on Cardiovascular Disease in the Young, American Heart Association
ATE217486T1 (de) Herstellung eines pflanzlichen milchpulvers
CA2081348A1 (en) Veterinary formulation of amoxycillin and clavulanic acid, and derivatives thereof
Annison Feed enzymes: the science of their use in wheat-based diets
HUT61895A (en) Process for producing pharmaceutical composition against cancer and aids
FR2387606A1 (fr) Aliment humide pour animaux domestiques et son procede de preparation
ES2143442A1 (es) Aplicacion del levamisol en la fabricacion de productos dieteticos promotores del crecimiento para peces.
HUT38807A (en) Flavoured synthetic crisp bone of high hardness